Kevin J. Gaffney,Kathleen E. Rodgers,Stan G. Louie,Gere S. Dizerega,Nicos A. Petasis
申请号：
US15318735
公开号：
US09943509B2
申请日:
2015.07.17
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention provides methods, compounds and compositions for the treatment of musculoskeletal disease, muscle dysfunction, muscle-wasting disease or disorder, including hereditary myopathy, neuromuscular disease, muscular dystrophy, muscular atrophy, drug-induced myopathy, and related disease, disorder or condition that causes a decrease in muscle strength, comprising the use of heterocyclic non-peptidic compounds that act as Mas agonists and/or mimics of angiotensin 1-7.
